HUP0201791A3 - The use of escitalopram for treatment of neurotic disorders - Google Patents

The use of escitalopram for treatment of neurotic disorders

Info

Publication number: HUP0201791A3
Authority: HU; Hungary
Prior art keywords: escitalopram; treatment; neurotic disorders; neurotic; disorders
Prior art date: 1999-07-08

Application number

HU0201791A

Other languages

English (en)

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-08

Filing date

2000-07-07

Publication date

2005-02-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8099796&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0201791(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-07-07 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

2002-10-28 Publication of HUP0201791A2 publication Critical patent/HUP0201791A2/hu

2005-02-28 Publication of HUP0201791A3 publication Critical patent/HUP0201791A3/hu

Links

206010029333 Neurosis Diseases 0.000 title 1
WSEQXVZVJXJVFP-FQEVSTJZSA-N escitalopram Chemical compound C1([C@]2(C3=CC=C(C=C3CO2)C#N)CCCN(C)C)=CC=C(F)C=C1 WSEQXVZVJXJVFP-FQEVSTJZSA-N 0.000 title 1
229960004341 escitalopram Drugs 0.000 title 1
208000015238 neurotic disease Diseases 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Anesthesiology (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Plural Heterocyclic Compounds (AREA)
Compounds Of Unknown Constitution (AREA)

HU0201791A 1999-07-08 2000-07-07 The use of escitalopram for treatment of neurotic disorders HUP0201791A3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DKPA199900991		1999-07-08

Publications (2)

Publication Number	Publication Date
HUP0201791A2 HUP0201791A2 (en)	2002-10-28
HUP0201791A3 true HUP0201791A3 (en)	2005-02-28

Family

ID=8099796

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU0201791A HUP0201791A3 (en)	1999-07-08	2000-07-07	The use of escitalopram for treatment of neurotic disorders

Country Status (38)

Country	Link
US (6)	US7271194B2 (hu)
EP (4)	EP1440691A3 (hu)
JP (1)	JP4773011B2 (hu)
KR (1)	KR100604176B1 (hu)
CN (1)	CN1198610C (hu)
AR (1)	AR021155A1 (hu)
AT (1)	ATE339955T1 (hu)
AU (6)	AU782514B2 (hu)
BG (4)	BG110466A (hu)
BR (1)	BR0011578A (hu)
CA (4)	CA2687392A1 (hu)
CL (3)	CL2008003941A1 (hu)
CO (1)	CO5190674A1 (hu)
CY (1)	CY1105806T1 (hu)
CZ (1)	CZ200270A3 (hu)
DE (1)	DE60030861T2 (hu)
DK (1)	DK1200081T3 (hu)
EA (1)	EA006555B1 (hu)
ES (1)	ES2272298T3 (hu)
HK (1)	HK1048069B (hu)
HR (1)	HRP20010820A2 (hu)
HU (1)	HUP0201791A3 (hu)
IL (5)	IL146131A0 (hu)
IS (1)	IS6137A (hu)
ME (2)	ME00032B (hu)
MX (1)	MXPA01011626A (hu)
MY (1)	MY143278A (hu)
NO (4)	NO329021B1 (hu)
PL (1)	PL352030A1 (hu)
PT (1)	PT1200081E (hu)
SI (1)	SI1200081T1 (hu)
SK (1)	SK82002A3 (hu)
TR (4)	TR200402276T2 (hu)
TW (1)	TWI232101B (hu)
UA (1)	UA77645C2 (hu)
WO (1)	WO2001003694A1 (hu)
YU (1)	YU78701A (hu)
ZA (1)	ZA200108856B (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR021155A1 (es)	1999-07-08	2002-06-12	Lundbeck & Co As H	Tratamiento de desordenes neuroticos
GB0005477D0 (en)	2000-03-07	2000-04-26	Resolution Chemicals Limited	Process for the preparation of citalopram
BR0113011A (pt)	2000-07-21	2003-07-01	Lundbeck & Co As H	Novos compostos e sua utilização como inibidores de transporte de glicina; composição farmacêutica e método do tratamento
SK14612003A3 (sk) *	2001-05-01	2004-04-06	H. Lundbeck A/S	Použitie enantiomérne čistého escitalopramu a farmaceutický prostriedok s obsahom escitalopramu
EP1522539B1 (en)	2001-07-31	2007-01-24	H. Lundbeck A/S	Crystalline composition containing escitalopram
AU2003237524A1 (en) *	2002-07-08	2004-01-23	University Of Florida	Use of ssri inhibitors to prevent or ameliorate trauma-related psychological disorders
US20050137255A1 (en) *	2002-12-23	2005-06-23	H. Lundbeck A/S	Crystalline escitalopram hydrobromide and methods for preparing the same
CA2511142A1 (en) *	2002-12-23	2004-07-08	H. Lundbeck A/S	Escitalopram hydrobromide and a method for the preparation thereof
AU2003223105A1 (en) *	2003-03-24	2004-10-18	Hetero Drugs Limited	Novel crystalline forms of (s)-citalopram oxalate
US20090093461A1 (en) *	2003-07-02	2009-04-09	Astrazeneca Ab	Methods of Treating Anxiety and Mood Disorders
EP1708790B1 (en) *	2003-12-02	2010-04-21	PharmaNeuroBoost N.V.	Use of pipamperone and a d2-receptor antagonist or a serotonin/dopamin antagonist for the treatment of psychotic disorders
US7855195B2 (en) *	2003-12-02	2010-12-21	Pharmaneuroboost N.V.	Method of treating mental disorders using D4 and 5-HT2A antagonists, inverse agonists or partial agonists
US7884096B2 (en) *	2003-12-02	2011-02-08	Pharmaneuroboost N.V.	Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
EP1954257A4 (en)	2005-10-14	2009-05-20	Lundbeck & Co As H	METHOD FOR TREATING DISORDERS OF THE CENTRAL NERVOUS SYSTEM WITH A LOW-DOSED COMBINATION OF ESCITALOPRAM AND BUPROPION
US20070134322A1 (en) *	2005-12-14	2007-06-14	Forest Laboratories, Inc.	Modified and pulsatile release pharmaceutical formulations of escitalopram
FR2912057B1 (fr) *	2007-02-07	2009-04-17	Sanofi Aventis Sa	Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
TW200817003A (en) *	2006-07-31	2008-04-16	Sanofi Aventis	Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1143703A (hu) *	1965-03-18
GB1526331A (en) *	1976-01-14	1978-09-27	Kefalas As	Phthalanes
US4439545A (en)	1981-11-19	1984-03-27	Societe D "Expansion Scientifique "Expansia"	Acrylic copolymers of N-acryloylpolymethyleneimines or N-acryloyldialkylamides, N,N'-acryloyldiaminoalcanes and N-acryloylaminoacids (or esters) their preparation and use as cation exchangers
GB8419963D0 (en) *	1984-08-06	1984-09-12	Lundbeck & Co As H	Intermediate compound and method
GB8607313D0 (en) *	1986-03-25	1986-04-30	Ici Plc	Pharmaceutical compositions
GB8814057D0 (en) *	1988-06-14	1988-07-20	Lundbeck & Co As H	New enantiomers & their isolation
US4902710A (en) *	1988-12-14	1990-02-20	Eli Lilly And Company	Serotonin and norepinephrine uptake inhibitors
US5114976A (en) *	1989-01-06	1992-05-19	Norden Michael J	Method for treating certain psychiatric disorders and certain psychiatric symptoms
US4962128A (en) *	1989-11-02	1990-10-09	Pfizer Inc.	Method of treating anxiety-related disorders using sertraline
US5296507A (en) *	1990-09-06	1994-03-22	H.Lundbeck A/S	Treatment of cerbrovascular disorders
DK213290D0 (da)	1990-09-06	1990-09-06	Lundbeck & Co As H	Treatment of cerebrovascular disorders
US5708035A (en) *	1991-02-04	1998-01-13	Sepracor Inc.	Methods of use and compositions of R(-) fluoxetine
WO1992018005A1 (en)	1991-04-16	1992-10-29	National Institutes Of Health	Method of treating trichotillomania and onychophagia
ATE244563T1 (de)	1991-11-15	2003-07-15	Sepracor Inc	Verwendung von reinem fluoxetin-s(+)-isomer für die herstellung eines medikements gegen migräne
EP0714663A3 (en) *	1994-11-28	1997-01-15	Lilly Co Eli	Potentiation of drug responses by serotonin 1A receptor antagonists
US5627196A (en) *	1995-01-17	1997-05-06	Eli Lilly And Company	Compounds having effects on serotonin-related systems
AU4918796A (en) *	1995-02-10	1996-08-27	Eli Lilly And Company	Methods of treating or preventing psychiatric disorders
US5554383A (en) *	1995-04-06	1996-09-10	Trustees Of Tufts College	Veterinary method for clinically modifying the behavior of dogs exhibiting canine affective aggression
SE9501567D0 (sv) *	1995-04-27	1995-04-27	Astra Ab	A new combination
ES2145977T3 (es)	1995-08-16	2000-07-16	Lilly Co Eli	Potenciacion de la respuesta de la serotonina.
US5846982A (en) *	1996-06-14	1998-12-08	Eli Lilly And Company	Inhibition of serotonin reuptake
US5912256A (en) *	1996-06-20	1999-06-15	Eli Lilly And Company	Compounds having effects on serotonin-related systems
US5747494A (en) *	1996-06-28	1998-05-05	U C B S.A.	Pharmaceutical compositions for the treatment of depressive disorders
US5958429A (en) *	1996-08-16	1999-09-28	Eli Lilly And Company	Potentiation of serotonin response
ZA977967B (en) *	1996-09-23	1999-03-04	Lilly Co Eli	Combination therapy for treatment of psychoses
US5776969A (en) *	1997-02-27	1998-07-07	Eli Lilly And Company	Treatment of sleep disorders
US6069177A (en) *	1997-07-08	2000-05-30	The Hong Kong University Of Science And Technology	3-Hydroxy-propanamine derived neuronal reuptake inhibitors
SE9703375D0 (sv) *	1997-09-18	1997-09-18	Astra Ab	A new combination
SE9703379D0 (sv) *	1997-09-18	1997-09-18	Astra Ab	New compounds
CA2291072C (en) *	1997-11-11	2002-08-20	H. Lundbeck A/S	Method for the preparation of citalopram
DK0957099T3 (da) *	1998-04-15	2003-03-17	Pfizer Prod Inc	Heterocykliske carboxamider
AU4850199A (en) *	1998-06-30	2000-01-17	Eli Lilly And Company	Pyrrolidine and pyrroline derivatives having effects on serotonin related systems
DE69935331T2 (de)	1998-07-13	2007-10-31	NPS Pharmaceuticals, Inc., Salt Lake City	Verfahren und verbindungen zur behandlung der depression
US6579899B1 (en)	1998-07-16	2003-06-17	Massachusetts Institute Of Technology	Composition for treatment of stress
EP1096927A4 (en)	1998-07-16	2002-09-04	Massachusetts Inst Technology	STRESS TREATMENT COMPOSITION
US6150376A (en) *	1998-08-05	2000-11-21	Georgetown University	Bi- and tri-cyclic aza compounds and their uses
SE9803158D0 (sv) *	1998-09-16	1998-09-16	Astra Ab	A new composition
SE9803157D0 (sv)	1998-09-16	1998-09-16	Astra Ab	A new composition
HU228576B1 (en) *	1998-10-20	2013-04-29	Lundbeck & Co As H	Method for the preparation of citalopram
AR021509A1 (es) *	1998-12-08	2002-07-24	Lundbeck & Co As H	Derivados de benzofurano, su preparacion y uso
ATE237604T1 (de) *	1999-04-14	2003-05-15	Lundbeck & Co As H	Verfahren zur herstellung von citalopram
AR021155A1 (es)	1999-07-08	2002-06-12	Lundbeck & Co As H	Tratamiento de desordenes neuroticos
US6333357B1 (en) *	1999-11-05	2001-12-25	Be Able, Llc	Behavior chemotherapy
UA77650C2 (en) *	1999-12-06	2007-01-15	Lundbeck & Co As H	Use of serotonin reuptake inhibitor in combination with deramcyclane
GB2357762B (en) *	2000-03-13	2002-01-30	Lundbeck & Co As H	Crystalline base of citalopram
AU5565401A (en) *	2000-04-24	2001-11-07	Aryx Therapeutics	Materials and methods for the treatment of depression
JP2002361405A (ja) *	2000-09-25	2002-12-18	Showa Denko Kk	熱交換器の製造方法
SK14612003A3 (sk) *	2001-05-01	2004-04-06	H. Lundbeck A/S	Použitie enantiomérne čistého escitalopramu a farmaceutický prostriedok s obsahom escitalopramu

2000
- 2000-07-06 AR ARP000103442A patent/AR021155A1/es unknown
- 2000-07-07 CO CO00051031A patent/CO5190674A1/es not_active Application Discontinuation
- 2000-07-07 BR BR0011578-9A patent/BR0011578A/pt active Search and Examination
- 2000-07-07 YU YU78701A patent/YU78701A/sh unknown
- 2000-07-07 EP EP04007522A patent/EP1440691A3/en not_active Withdrawn
- 2000-07-07 EP EP04007520A patent/EP1440689A3/en not_active Withdrawn
- 2000-07-07 DE DE60030861T patent/DE60030861T2/de not_active Expired - Lifetime
- 2000-07-07 PL PL00352030A patent/PL352030A1/xx not_active Application Discontinuation
- 2000-07-07 SI SI200030910T patent/SI1200081T1/sl unknown
- 2000-07-07 AU AU58061/00A patent/AU782514B2/en not_active Expired
- 2000-07-07 CA CA2687392A patent/CA2687392A1/en not_active Abandoned
- 2000-07-07 ME MEP-2008-25A patent/ME00032B/me unknown
- 2000-07-07 JP JP2001508974A patent/JP4773011B2/ja not_active Expired - Lifetime
- 2000-07-07 KR KR1020017016006A patent/KR100604176B1/ko not_active IP Right Cessation
- 2000-07-07 TR TR2004/02276T patent/TR200402276T2/xx unknown
- 2000-07-07 EA EA200200137A patent/EA006555B1/ru not_active IP Right Cessation
- 2000-07-07 TR TR2002/00014T patent/TR200200014T2/xx unknown
- 2000-07-07 CZ CZ200270A patent/CZ200270A3/cs unknown
- 2000-07-07 PT PT00943692T patent/PT1200081E/pt unknown
- 2000-07-07 TR TR2004/02277T patent/TR200402277T2/xx unknown
- 2000-07-07 ES ES00943692T patent/ES2272298T3/es not_active Expired - Lifetime
- 2000-07-07 ME MEP-25/08A patent/MEP2508A/xx unknown
- 2000-07-07 MX MXPA01011626A patent/MXPA01011626A/es not_active Application Discontinuation
- 2000-07-07 TR TR2004/02275T patent/TR200402275T2/xx unknown
- 2000-07-07 MY MYPI20003122A patent/MY143278A/en unknown
- 2000-07-07 AT AT00943692T patent/ATE339955T1/de active
- 2000-07-07 CA CA002373757A patent/CA2373757C/en not_active Expired - Lifetime
- 2000-07-07 IL IL14613100A patent/IL146131A0/xx unknown
- 2000-07-07 UA UA2001128286A patent/UA77645C2/uk unknown
- 2000-07-07 HU HU0201791A patent/HUP0201791A3/hu unknown
- 2000-07-07 EP EP00943692A patent/EP1200081B1/en not_active Revoked
- 2000-07-07 SK SK8-2002A patent/SK82002A3/sk not_active Application Discontinuation
- 2000-07-07 CA CA2687394A patent/CA2687394A1/en not_active Abandoned
- 2000-07-07 CA CA2687396A patent/CA2687396A1/en not_active Abandoned
- 2000-07-07 WO PCT/DK2000/000377 patent/WO2001003694A1/en active Application Filing
- 2000-07-07 EP EP04007521A patent/EP1440690A3/en not_active Withdrawn
- 2000-07-07 DK DK00943692T patent/DK1200081T3/da active
- 2000-07-07 CN CNB008100292A patent/CN1198610C/zh not_active Expired - Lifetime
- 2000-07-28 TW TW089115110A patent/TWI232101B/zh not_active IP Right Cessation
2001
- 2001-10-23 IL IL146131A patent/IL146131A/en active IP Right Grant
- 2001-10-26 ZA ZA200108856A patent/ZA200108856B/xx unknown
- 2001-10-30 IS IS6137A patent/IS6137A/is unknown
- 2001-11-06 HR HR20010820A patent/HRP20010820A2/hr not_active Application Discontinuation
- 2001-12-12 US US10/021,126 patent/US7271194B2/en not_active Expired - Lifetime
2002
- 2002-01-04 BG BG11046609A patent/BG110466A/bg unknown
- 2002-01-04 BG BG11046709A patent/BG110467A/bg unknown
- 2002-01-04 BG BG106279A patent/BG106279A/bg unknown
- 2002-01-04 BG BG11046809A patent/BG110468A/bg unknown
- 2002-01-07 NO NO20020062A patent/NO329021B1/no not_active IP Right Cessation
2003
- 2003-01-09 HK HK03100231.6A patent/HK1048069B/zh not_active IP Right Cessation
- 2003-08-07 US US10/637,822 patent/US20040029958A1/en not_active Abandoned
- 2003-08-07 US US10/637,821 patent/US20040029957A1/en not_active Abandoned
- 2003-08-07 US US10/637,820 patent/US7265151B2/en not_active Expired - Lifetime
- 2003-08-20 US US10/644,143 patent/US6960613B2/en not_active Expired - Lifetime
2005
- 2005-06-20 AU AU2005202686A patent/AU2005202686B2/en not_active Expired
- 2005-06-20 AU AU2005202685A patent/AU2005202685B2/en not_active Ceased
- 2005-06-20 AU AU2005202684A patent/AU2005202684B2/en not_active Ceased
- 2005-08-09 IL IL170192A patent/IL170192A/en unknown
- 2005-08-09 IL IL170193A patent/IL170193A/en unknown
- 2005-08-09 IL IL170194A patent/IL170194A/en unknown
2006
- 2006-11-27 CY CY20061101706T patent/CY1105806T1/el unknown
2007
- 2007-08-10 US US11/837,317 patent/US20070276035A1/en not_active Abandoned
2008
- 2008-12-24 AU AU2008264188A patent/AU2008264188A1/en not_active Withdrawn
- 2008-12-24 AU AU2008264182A patent/AU2008264182A1/en not_active Withdrawn
- 2008-12-30 CL CL2008003941A patent/CL2008003941A1/es unknown
- 2008-12-30 CL CL2008003938A patent/CL2008003938A1/es unknown
- 2008-12-30 CL CL2008003939A patent/CL2008003939A1/es unknown
2010
- 2010-03-10 NO NO20100334A patent/NO20100334L/no not_active Application Discontinuation
- 2010-03-10 NO NO20100335A patent/NO20100335L/no not_active Application Discontinuation
- 2010-03-10 NO NO20100333A patent/NO20100333L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
NO20020062D0 (no)	2002-01-07
KR100604176B1 (ko)	2006-07-25
ATE339955T1 (de)	2006-10-15
NO20100333L (no)	2002-01-07
CA2687392A1 (en)	2001-01-18
TR200200014T2 (tr)	2002-05-21
AU2005202684B2 (en)	2009-01-15
TR200402276T2 (tr)	2005-01-24
NO329021B1 (no)	2010-07-26
EP1440689A2 (en)	2004-07-28
CL2008003941A1 (es)	2009-05-22
IL170193A (en)	2010-04-29
HUP0201791A2 (en)	2002-10-28
BG110466A (en)	2010-01-29
ME00032B (me)	2010-02-10
MEP2508A (xx)	2010-02-10
BG110467A (en)	2010-01-29
EP1440691A3 (en)	2004-08-25
SK82002A3 (en)	2002-07-02
NO20100334L (no)	2002-01-07
TWI232101B (en)	2005-05-11
EP1440690A2 (en)	2004-07-28
US20040029956A1 (en)	2004-02-12
US7265151B2 (en)	2007-09-04
CO5190674A1 (es)	2002-08-29
US20040029957A1 (en)	2004-02-12
AR021155A1 (es)	2002-06-12
NO20020062L (no)	2002-01-07
SI1200081T1 (sl)	2007-02-28
US7271194B2 (en)	2007-09-18
AU2005202685B2 (en)	2009-01-15
TR200402277T2 (tr)	2005-01-24
IL170192A (en)	2010-04-29
CN1198610C (zh)	2005-04-27
JP2003504332A (ja)	2003-02-04
AU2005202686A1 (en)	2005-07-14
AU5806100A (en)	2001-01-30
HK1048069B (zh)	2005-12-16
YU78701A (sh)	2004-03-12
CZ200270A3 (cs)	2002-04-17
AU2008264182A1 (en)	2009-01-29
EP1200081B1 (en)	2006-09-20
CN1360501A (zh)	2002-07-24
DE60030861T2 (de)	2007-05-03
AU2005202685A1 (en)	2005-07-14
HK1048069A1 (en)	2003-03-21
US6960613B2 (en)	2005-11-01
EA006555B1 (ru)	2006-02-24
BG110468A (en)	2010-01-29
US20070276035A1 (en)	2007-11-29
DK1200081T3 (da)	2006-12-27
DE60030861D1 (de)	2006-11-02
PT1200081E (pt)	2007-01-31
EP1440690A3 (en)	2004-08-18
UA77645C2 (en)	2007-01-15
US20040029958A1 (en)	2004-02-12
TR200402275T2 (tr)	2005-03-21
US20020086899A1 (en)	2002-07-04
EP1200081A1 (en)	2002-05-02
EP1440689A3 (en)	2004-08-25
AU782514B2 (en)	2005-08-04
CA2373757C (en)	2010-01-05
IL170194A (en)	2010-05-31
NO20100335L (no)	2002-01-07
ES2272298T3 (es)	2007-05-01
KR20020015346A (ko)	2002-02-27
CL2008003938A1 (es)	2009-05-22
IL146131A (en)	2007-02-11
CA2687394A1 (en)	2001-01-18
WO2001003694A1 (en)	2001-01-18
IS6137A (is)	2001-10-30
CA2373757A1 (en)	2001-01-18
US20050101665A1 (en)	2005-05-12
AU2008264188A1 (en)	2009-05-07
BG106279A (bg)	2002-08-30
CL2008003939A1 (es)	2009-06-05
MY143278A (en)	2011-04-15
EA200200137A1 (ru)	2002-06-27
JP4773011B2 (ja)	2011-09-14
MXPA01011626A (es)	2002-06-04
HRP20010820A2 (en)	2003-08-31
AU2005202686B2 (en)	2009-01-15
ZA200108856B (en)	2002-12-24
IL146131A0 (en)	2002-07-25
PL352030A1 (en)	2003-07-28
CY1105806T1 (el)	2011-02-02
CA2687396A1 (en)	2001-01-18
AU2005202684A1 (en)	2005-07-14
EP1440691A2 (en)	2004-07-28
BR0011578A (pt)	2002-03-26

Legal Events

Date	Code	Title	Description
2013-04-29	FD9A	Lapse of provisional protection due to non-payment of fees

Publication	Publication Date	Title
GB0007193D0 (en)	2000-05-17	Treatment of movrmrnt disorders
PL351134A1 (en)	2003-03-24	Compositions for treatment of disorders of the oesophagus
EP1063990A4 (en)	2003-01-02	THERAPY FOR ESTROGEN RELATED DISORDERS
AU8187701A (en)	2002-01-14	Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
HUP0201791A3 (en)	2005-02-28	The use of escitalopram for treatment of neurotic disorders
IL151890A0 (en)	2003-04-10	Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL161267A0 (en)	2004-09-27	Combinations for the treatment of immunoinflammatory disorders
EP1126850A4 (en)	2003-01-15	TREATMENT OF CONDITIONS OF THE RETINA
ID27214A (id)	2001-03-08	Triazolopiridina untuk pengobatan gangguan trombosis
IL151765A0 (en)	2003-04-10	Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL151891A0 (en)	2003-04-10	Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
GB9926968D0 (en)	2000-01-12	Treatment of neurological disorders
MXPA03004190A (es)	2003-09-22	Tratamiento de trastornos de ansiedad.
IL140540A0 (en)	2002-02-10	Treatment of anxiety disorders
CZ20011872A3 (cs)	2002-03-13	Isonipekotamidy pro léčbu onemocnění zprostředkovaných integriny
GB0010496D0 (en)	2000-06-14	Treatment of conditions of the central nervous system
GB9924942D0 (en)	1999-12-22	Treatment of movement disorders
GB9816353D0 (en)	1998-09-23	The treatment of viral disorders
GB9816355D0 (en)	1998-09-23	The treatment of viral disorders
GB9923551D0 (en)	1999-12-08	Treatment of neuropsychiatric disorders
GB9815188D0 (en)	1998-09-09	Treatment of skin disorders
GB9918058D0 (en)	1999-10-06	Compound for treatment of gi disorders
GB0003228D0 (en)	2000-04-05	Treatment of GI disorders
GB0017951D0 (en)	2000-09-13	Treatment of movement disorders
GB0029955D0 (en)	2001-01-24	Treatment of neuropsychiatric disorders